SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000031
Filing Date
2022-02-28
Accepted
2022-02-28 08:15:13
Documents
21
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220228.htm   iXBRL 8-K 40483
2 EX-99.1 a4q2021earningspressrele.htm EX-99.1 32324
6 a4q2021earningspressrele001.jpg GRAPHIC 258548
7 a4q2021earningspressrele002.jpg GRAPHIC 285864
8 a4q2021earningspressrele003.jpg GRAPHIC 313612
9 a4q2021earningspressrele004.jpg GRAPHIC 326560
10 a4q2021earningspressrele005.jpg GRAPHIC 364809
11 a4q2021earningspressrele006.jpg GRAPHIC 255607
12 a4q2021earningspressrele007.jpg GRAPHIC 146806
13 a4q2021earningspressrele008.jpg GRAPHIC 119825
  Complete submission text file 0001485003-22-000031.txt   3079197

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220228.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220228_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220228_pre.xml EX-101.PRE 13190
15 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220228_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22684008
SIC: 2834 Pharmaceutical Preparations